Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system

Archives of Virology

Volumn 161, Issue 6, 2016, Pages 1447-1454

  Suda, Yuto ^a,b   Fukushi, Shuetsu ^b   Tani, Hideki ^b   Murakami, Shin ^a   Saijo, Masayuki ^b   Horimoto, Taisuke ^a   Shimojima, Masayuki ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN; VIRUS ENVELOPE PROTEIN;

ANIMAL; CHLOROCEBUS AETHIOPS; GENETICS; HEK293 CELL LINE; HEMORRHAGIC FEVER, CRIMEAN; HUMAN; JURKAT CELL LINE; NAIROVIRUS; PATHOGENICITY; PHYSIOLOGY; VERO CELL LINE; VESICULAR STOMATITIS INDIANA VIRUS; VIROLOGY; VIRUS ENTRY;

ANIMALS; CELL ADHESION MOLECULES; CERCOPITHECUS AETHIOPS; HEK293 CELLS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; JURKAT CELLS; LECTINS, C-TYPE; RECEPTORS, CELL SURFACE; VERO CELLS; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84959523423     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-016-2803-1     Document Type: Article

References (44)

1. Bente D, Forrester N, Watts D et al (2013) Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir Res 100:159–189. doi:10.1016/j.antiviral.2013.07.006
2. Mertens M, Schmidt K, Ozkul A, Groschup MH (2013) The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral Res 98:248–260. doi:10.1016/j.antiviral.2013.02.007
3. Whitehouse CA (2004) Crimean-Congo hemorrhagic fever. Antiviral Res 64:145–160. doi:10.1016/j.antiviral.2004.08.001
4. Papa A, Weber F, Hewson R et al (2015) Meeting report: First International Conference on Crimean-Congo hemorrhagic fever. Antiviral Res 120:57–65. doi:10.1016/j.antiviral.2015.05.005
5. Messina JP, Pigott DM, Golding N et al (2015) The global distribution of Crimean-Congo hemorrhagic fever. Trans R Soc Trop Med Hyg 109:503–513. doi:10.1093/trstmh/trv050
6. Akıncı E, Bodur H, Leblebicioglu H (2013) Pathogenesis of crimean-congo hemorrhagic Fever. Vector Borne Zoonotic Dis 13:429–437. doi:10.1089/vbz.2012.1061
7. Papa A, Ma B, Kouidou S et al (2002) Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China. Emerg Infect Dis 8:50–53
8. Nurmakhanov T, Sansyzbaev Y, Atshabar B et al (2015) Crimean-Congo haemorrhagic fever virus in Kazakhstan (1948-2013). Int J Infect Dis 38:19–23. doi:10.1016/j.ijid.2015.07.007
9. Virus Taxonomy (2014) EC 46, Montreal, Canada, July 2014, Email ratification 2015 (MSL #29)
10. Sanchez AJ, Vincent MJ, Nichol ST (2002) Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J Virol 76:7263–7275
11. Vincent MJ, Sanchez AJ, Erickson BR et al (2003) Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J Virol 77:8640–8649
12. Bergeron E, Vincent MJ, Nichol ST (2007) Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J Virol 81:13271–13276. doi:10.1128/JVI.01647-07
13. Bertolotti-Ciarlet A, Smith J, Strecker K et al (2005) Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins. J Virol 79:6152–6161. doi:10.1128/JVI.79.10.6152-6161.2005
14. Simon M, Johansson C, Mirazimi A (2009) Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J Gen Virol 90:210–215. doi:10.1099/vir.0.006387-0
15. Garrison AR, Radoshitzky SR, Kota KP et al (2013) Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology 444:45–54. doi:10.1016/j.virol.2013.05.030
16. Shi X, Kohl A, Li P, Elliott RM (2007) Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis. J Virol 81:10151–10160. doi:10.1128/JVI.00573-07
17. Overby AK, Popov VL, Pettersson RF, Neve EPA (2007) The cytoplasmic tails of Uukuniemi Virus (Bunyaviridae) G(N) and G(C) glycoproteins are important for intracellular targeting and the budding of virus-like particles. J Virol 81:11381–11391. doi:10.1128/JVI.00767-07
18. Carnec X, Ermonval M, Kreher F et al (2014) Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis. Virology 448:1–14. doi:10.1016/j.virol.2013.09.023
19. Tamin A, Harcourt BH, Lo MK et al (2009) Development of a neutralization assay for Nipah virus using pseudotype particles. J Virol Methods 160:1–6. doi:10.1016/j.jviromet.2009.02.025
20. Fukushi S, Mizutani T, Saijo M et al (2005) Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol 86:2269–2274. doi:10.1099/vir.0.80955-0
21. Ogino M, Ebihara H, Lee B-H et al (2003) Use of Vesicular Stomatitis Virus Pseudotypes Bearing Hantaan or Seoul Virus Envelope Proteins in a Rapid and Safe Neutralization Test. Clin Vaccine Immunol 10:154–160. doi:10.1128/CDLI.10.1.154-160.2003
22. Tani H, Iha K, Shimojima M et al (2014) Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J Virol 88:7317–7330. doi:10.1128/JVI.00512-14
23. Taniguchi S, Sayama Y, Nagata N et al (2012) Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines. BMC Vet Res 8:189. doi:10.1186/1746-6148-8-189
24. Sayama Y, Demetria C, Saito M et al (2012) A seroepidemiologic study of Reston ebolavirus in swine in the Philippines. BMC Vet Res 8:82. doi:10.1186/1746-6148-8-82
25. Tani H, Komoda Y, Matsuo E et al (2007) Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J Virol 81:8601–8612. doi:10.1128/JVI.00608-07
26. Takada A, Robison C, Goto H et al (1997) A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA 94:14764–14769
27. Xiao X, Feng Y, Zhu Z, Dimitrov DS (2011) Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem Biophys Res Commun 411:253–258. doi:10.1016/j.bbrc.2011.06.109
28. Geijtenbeek TB, Kwon DS, Torensma R et al (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587–597
29. de Witte L, de Vries RD, van der Vlist M et al (2008) DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 4:e1000049. doi:10.1371/journal.ppat.1000049
30. Tassaneetrithep B, Burgess TH, Granelli-Piperno A et al (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197:823–829. doi:10.1084/jem.20021840
31. Marzi A, Gramberg T, Simmons G et al (2004) DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 78:12090–12095. doi:10.1128/JVI.78.21.12090-12095.2004
32. Shimojima M, Ströher U, Ebihara H et al (2012) Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. J Virol 86:2067–2078. doi:10.1128/JVI.06451-11
33. Lozach P-Y, Kühbacher A, Meier R et al (2011) DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10:75–88. doi:10.1016/j.chom.2011.06.007
34. Hofmann H, Li X, Zhang X et al (2013) Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J Virol 87:4384–4394. doi:10.1128/JVI.02628-12
35. Erickson BR, Deyde V, Sanchez AJ et al (2007) N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport. Virology 361:348–355. doi:10.1016/j.virol.2006.11.023
36. Shimojima M, Takada A, Ebihara H et al (2006) Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 80:10109–10116. doi:10.1128/JVI.01157-06
37. Shimojima M, Nishimura Y, Miyazawa T et al (2002) A feline CD2 homologue interacts with human red blood cells. Immunology 105:360–366
38. Carneiro FA, Ferradosa AS, Da Poian AT (2001) Low pH-induced conformational changes in vesicular stomatitis virus glycoprotein involve dramatic structure reorganization. J Biol Chem 276:62–67. doi:10.1074/jbc.M008753200
39. Powlesland AS, Fisch T, Taylor ME et al (2008) A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem 283:593–602. doi:10.1074/jbc.M706292200
40. Shtanko O, Nikitina RA, Altuntas CZ et al (2014) Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators. PLoS Pathog 10:e1004390. doi:10.1371/journal.ppat.1004390
41. Connolly-Andersen A-M, Douagi I, Kraus AA, Mirazimi A (2009) Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 390:157–162. doi:10.1016/j.virol.2009.06.010
42. Burt FJ, Swanepoel R, Shieh WJ et al (1997) Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 121:839–846
43. Geijtenbeek TBH, Engering A, Van Kooyk Y (2002) DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J Leukoc Biol 71:921–931
44. Zhang F, Ren S, Zuo Y (2014) DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection. Int Rev Immunol 33:54–66. doi:10.3109/08830185.2013.834897